Given the role of KCa3.1 and KCa2.3 in modulating vascular tone and hence BP, it is possible that hypertensive events occurring in patients with CF are the result of KCa3.1 and KCa2.X inhibition in vascular endothelia. The gene discussed is KCNN3; the disease is cystic fibrosis.